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Several of the priority pollutants discussed in EPA's Ambient Water Quality Criteria documents
have been reported to have promotion or cocarcinogenic activity. For example, phenol appears to
have tumor-promoting activity in mice when repeatedly applied after initiation with either 7,12-di-
methyl-1,2-benzanthracene (DMBA) or benzo(a)pyrene (BaP). Similarly, it has been reported that
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a potent promoter of liver tumors as well as a cocarci-
nogen. However, in developing guidelines to derive ambient water quality criteria, it became ap-
parent that satisfactory approaches had not been developed for using promotion/cocarcinogen data
in human health risk estimation, nor were available promotion and/or cocarcinogen data on individ-
ual chemicals strong enough to permit a defensible quantitative risk estimation, if such approaches
had existed. For this reason, the criteria derived for pollutants with reported promotion/cocarcino-
genic activities were based on approaches for carcinogenic (e.g., TCDD), toxic (e.g., fluoranthene) or
organoleptic effects (e.g., 2,4-dichlorophenol).
Nonetheless, with advances in studies on both the biological mechanisms and dose/response pat-
terns of promoters and cocarcinogens, it may be possible to develop a scientifically valid quantita-
tive approach to use this type of data for derivation of ambient water quality criteria or other risk
assessments. Some progress toward this goal and the problems associated with this effort are
discussed.
Introduction
Of the 4 million chemicals present in the environ-
ment (1), more than 60,000 have been produced by
industry in the last two decades, and 500 to 700 new
compounds are added every year (2). Contamination
of surface water by these compounds results from
industrial or municipal discharges, accidental spill-
age during transportation, and other point or non-
point sources. Migration of these chemicals through
the soil from municipal land dump sites or other
sources results in contamination of underground
water.
A large number of these chemicals are toxic to
human health and many are confirmed or suspected
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carcinogens. Since these contaminants occur in very
low concentrations in the parts per billion or trillion
range, a large percentage of the population is ex-
posed to low doses over a long period of time. Sev-
eral reports indicate that a direct relationship exists
between increased incidence of cancer and the use
of water from certain rivers in the U.S. (3-10). Ex-
posure to these water pollutants does not only oc-
cur from drinking contaminated water but also from
consumption of fish from these contaminated
sources. Accordingly, our society has become in-
creasingly conscious of the presence of these chemi-
cal contaminants in the environment.
Under the Clean Water Act, the U.S. Environ-
mental Protection Agency (U.S. EPA) is required to
develop an approach for controlling the release of
hazardous pollutants in water. As part of this effort,
the Environmental Criteria and Assessment Office
(ECAO) in Cincinnati, with the support of the Carci-
nogen Assessment Group (CAG) in the Office of
Health and Environmental Assessment (OHEA) wasSTARA ETAL.
assigned the task of assessing the potential health
risks associated with contamination of the aquatic
environment. ECAO had overall responsibility to
prepare the Human Health Effects Assessment
Chapters and CAG was responsible for the carcino-
gen sections of the 65 Ambient Water Quality Cri-
teria Documents (AWQCD) which were required
under the Consent Decree (Environmental Defense
Fund vs. Train). With the assistance of scientists
from academic institutions, the private sector and
government, ECAO developed guidelines for de-
riving ambient water quality criteria and applied
these guidelines to the available data on the 129
compounds included in the 65 documents. Of the 129
priority pollutants for which criteria were eventu-
ally recommended, 43 were derived from carcino-
genicity data, 29 from toxicity data, and 23 from or-
ganoleptic data. For 6 of the 129 pollutants no cri-
teria were recommended. For some pollutants cri-
teria were derived based on carcinogenic or organo-
leptic effects; toxic effect-based protective levels
were also calculated for comparison.
The purpose of this paper is to present the ap-
proach that has been taken when confronted with
promotion and/or cocarcinogenic data in assessing
human health risk, and to raise questions so that im-
provements in the methods for assessing health risk
from promoters and cocarcinogens will be devel-
oped. It is necessary to generate data that not only
explain the mechanism of action of these agents but
also to provide a satisfactory data base for quantita-
tive risk assessment.
Ambient Water Quality Criteria
The development of the methodology employed
to derive EPA's Ambient Water Quality Criteria
has been discussed previously in detail (11-13). The
following discussion is a concise review of the sali-
ent features of this methodology.
Ambient water quality criteria were derived
from data on three possible types of biological end-
points: carcinogenic, toxic (i.e., all adverse effects
other than cancer), and organoleptic effects. Carci-
nogenic response is regarded as a nonthreshold phe-
nomenon. Therefore, "safe" or "no-effect" levels for
carcinogens cannot be established because any dose
must be assumed to elicit a finite response. Toxic
and organoleptic effects are regarded as threshold
phenomena. Therefore "safe" levels can be estab-
lished.
After a review concluded that a compound had
the potential to cause cancer in humans and data ex-
isted to permit the derivation of a criterion, the
water concentration associated with a lifetime carci-
nogenic risk of 10-5 was estimated. The data used
for quantitative estimates were of two types: (a) life-
time animal bioassays, and (b) human epidemiologic
studies where excess cancer risk had been associ-
ated with exposure to the agent.
The method of risk assessment for a potential hu-
man carcinogen is not a clear-cut process. Several
biologically plausible mathematical models have
been used in the attempt to assess the risk. How-
ever, until the mechanism of carcinogenesis is
firmly established and universally accepted, no
single model can be identified which would in-
terpret the true molecular aspect of carcinogenesis.
Considering these uncertainties, a linear multistage
model was chosen to assess the risk of carcinogenic
substances in ambient water from data found in ani-
mal studies. The justification for the choice of this
model and its formulation are discussed in detail
elsewhere (13). Briefly, the multistage model (14) is
based on the assumption that neoplastic transforma-
tion of a cell occurs after it has encountered
heritable changes. Utilization of this model for esti-
mating risk from carcinogenic pollutants in water is
justified by the following characteristics:
* Carcinogens are or can be metabolized to elec-
trophiles that react with DNA of the cell re-
sulting in DNA damage, misrepair or in-
complete repair.
* Many carcinogens are mutagens which can be
detected by short-term tests, such as
Salmonella plate incorporation assay.
* Carcinogenesis is an irreversible self-replicat-
ing process.
* Carcinogenesis is a multistage process. The
simplest biological counterpart is the two-stage
initiator-promoter mechanism of carcinogene-
SiS.
* Mortality rates for several forms of cancer in
the adult population increase as the fifth or
sixth power of age, indicating cancer develops
by a multistage process.
If human epidemiologic data and sufficiently valid
exposure information are available for the com-
pound, the data are analyzed by an alternate proce-
dure to give an estimate of the linear dependence of
cancer rates based upon the calculated lifetime
average dose. If the epidemiology data show no
carcinogenic effect when positive animal evidence is
available, it is assumed that a risk exists but is
smaller than could have been observed in the epide-
miologic study. An upper limit of the cancer inci-
dence is then calculated, assuming that the true in-
cidence is just below the level of detection in the co-
hort studies. With this approach, the response is
measured in terms of excess risk of the exposed co-
hort of individuals compared to the control group.
In analyzing the data, it is assumed that the excess
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risk is proportional to the lifetime average exposure
and that it is the same for all ages (15).
Both of these procedures yield slopes termed
q,*(A) orBm for animal and human data respective-
ly. Since q,*(A) is derived from animal studies, it
must be adjusted to yield an equivalent human
slope, q,*(H), by the following equation:
q *(H)= - [ql*(A)] ( 70kg 1/3
(lelLe)(Le/L)3 w
where q,*(A) = the upper 95% estimate of the
linear component of the slope (potency factor) esti-
mated from all the animal data, in (mg/kg/day)-1; le
= the length of exposure; Le = the length of the
experiment; L = the lifespan of the animal; and w
= average weight of the animal (in kg). The (LeL)3
factor accounts for the increase in tumor incidence
in time during a chronic study. For example, if a
study lasted only one-half the normal lifespan of the
animal, then the lifetime incidence is expected to be
(2)3 = 8 times as high as the incidence at the end of
that study. Therefore, q,* is 8 times as large as the
value calculated from the incidence at time Le.
Higher values of q,*(I) are associated with lower,
more restrictive, ambient water criteria. The
rationale for the use of this factor is documented
elsewhere (13,15). The cube root of the body weight
ratios is a further refinement of the q,*(A) potency
factor, in that it represents an equivalent dose
among species (16).
After the slopes describing carcinogenic potency
in humans have been calculated, the intake I
associated with a specific risk (usually 10-5 or 1 in
100,000) over a human lifetime is determined:
I(mg/day) = 70kg(10- 5) 70 kg(10-5) [qj*(H)][mg/kg/day)-1] BH(mg/kg/day)-1
The ambient water quality criterion (AWQC) is then
calculated as follows:
C(mg/L) = I(mg/day)
(2 L/d) + ([0.0065 kg/day][BCF(L/kg)]}
For this calculation, the average weight of a man
is assumed to be 70 kg. The assumed average daily
consumption of water and fish for a 70 kg man is 2
L and 0.0065 kg, respectively. BCF is the bioconcen-
tration factor of the chemical (in L/kg).
For toxic compounds not manifesting any appar-
ent carcinogenicity the threshold assumption was
used in deriving a criterion. This assumption is
based on the premise that a physiological reserve
exists within the organism which must be depleted
before clinical disease ensues. In developing
guidelines for deriving criteria based on non-
carcinogenic responses, five types of response levels
are considered:
* NOEL: No Observed Effect Level
* NOAEL: No Observed Adverse Effect Level
* LOEL: Lowest Observed Effect Level
* LOAEL: Lowest Observed Adverse Effect
Level
* FEL: Frank Effect Level
Adverse effects are defined as those which result
in functional impairment and/or pathological lesions
which may affect the performance of the whole or-
ganism, or which reduced an organism's ability to
respond to an additional challenge. Frank effects
are defined as overt or gross adverse effects (severe
convulsions, lethality, etc.).
These concepts are illustrated in Figure 1
modified from dose-response curves proposed else-
where (17). They have received much attention be-
cause they represent landmarks which help to de-
fine the threshold region in specific experiments.
Thus, if an experiment yields a NOEL, a NOAEL, a
LOAEL and an FEL in relatively close spaced
doses, the threshold region has been relatively well
defined. Such data are very useful for the purpose
of deriving a criterion. On the other hand, a clearly
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FIGURE 1. Response levels considered in defining threshold
regions in toxicity experiments. Doses associated with
these levels are as follows: 3-NOEL, NOAEL; 4-LOEL,
NOAEL; 5-NOAEL (highest); 7-LOAEL; 10-FEL; 20-FEL.
Modified from dose-response curves proposed by Norberg
and Norseth (17).
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defined FEL has little utility in establishing criteria
when it stands alone, because such a level gives no
indication how far removed it is from the threshold
region. Similarly, a free-standing NOEL has little
utility, because there is no indication of its proximi-
ty to the threshold region.
Organoleptic criteria define concentrations of ma-
terials which impart undesirable taste and/or odor
to water, are not based on toxicologic information
and have no direct relationship to potential adverse
human health effects. Since organoleptic and human
health effects criteria are based on different end-
points, a distinction was made between these two
sets of information. In a number of cases, two ap-
proaches were used to derive criteria levels based
on available toxicity and organoleptic data. Where
sufficient data were not available to estimate a level
which would protect against the potential toxicity,
no criterion was derived.
In 1978-1979, when the guidelines were pre-
pared, it became apparent that satisfactory meth-
ods had not been developed for either an accurate
identification or usage of promotion/cocarcinogenic
data in quantitative risk assessment. Moreover, the
data on promoters or cocarcinogens did not permit
a quantitative estimation of health risks incurred by
this type of biological phenomenon. Therefore, in
light of these issues, some of the pollutants in the 65
ambient water quality criteria documents with pro-
motional activities (Table 1) were assigned criteria
based on their carcinogenic properties using the
modified multistage model. On the other hand, some
criteria for these chemicals were derived on toxicity
or organoleptic data because a sufficient data base
for carcinogenicity was not available or other fac-
tors (e.g., route of exposure, essentiality, nutritional
status of exposed individuals) played a role in the
review committee's judgment. In none of these
cases were promotion or cocarcinogenic data fac-
tored in developing the criteria (Table 2).
A few of these priority pollutants on which ambi-
ent water quality criteria were developed have
been reported to be promoters and/or cocarcino-
gens. For example, TCDD, a carcinogen, appears
also to be a promoter in hepatocarcinogenesis and a
cocarcinogen in the development of sarcoma. Simi-
larly, phenol, 2-chlorophenol, 2,4-dichlorophenol, fluo-
ranthene, DDT, dieldrin, beryllium, nickel, cadmium
Table 1. The 65 consent decree water criteria documents.
Acenaphthene
Acrolein
Acrylonitrile
Aldrin/dieldrina
Antimony
Arsenic
Asbestos
Benzene
Benzidine
Berylliuma
Cadmium (in vitro system)a
Carbon tetrachloride
Chlordane
Chlorinated benzenes
Chlorinated ethanes
Chlorinated naphthalene
Chlorinated phenols (3-chlorophenol)a
Chloroalkyl ethers
Chloroform
2-Chlorophenol
Chromium (in vitro system)a
Copper
Cyanide
DDTa
Dichlorobenzene
Dichlorobenzidine
Dichloroethylenes
2,4-Dichlorophenola
Dichloropropanes/enes
2,4-Dimethylphenol
2,4-Dinitrotoluene
Dioxins (TCDD)a
a Promoters and/or cocarcinogens
Diphenylhydrazine
Endosulfan
Endrin
Ethylbenzene
Fluoranthenea
Haloethers
Halomethanes
Heptachlor
Hexachlorobutadiene (HCBD)
Hexachlorocyclohexane
Hexachlorocyclopentadiene
Isophorone
Lead
Mercury
Naphthalene
Nickel (in vitro system)a
Nitrobenzene
Nitrophenols
Nitrosamines
PAHs
PCBs
Pentachlorophenol
Phenola
Phthalate esters
Selenium
Silver
Tetrachloroethylene
Thallium
Toluene
Toxaphene
Trichloroethylenes
Vinyl chloride
Zinc
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Table 2. Ambient Water Quality Criteria for priority pollutants with
reported promotion/cocarcinogenic activities.
Priority pollutant Criterion data base AWQC criterion, lAg/L
Berylliuma Carcinogenic 6.8 x 10-2
Cadmiumb Toxic 10
3-Chlorophenolc Organoleptic 0.10
Chromiumb Toxic 50
DDTa Carcinogenic 2.4 x 10-4
2,4-Dichlorophenolc Toxic 3.1 x 103
Organoleptic 0.3
Dieldrina Carcinogenic 7.1 x 10-4
Fluoranthenea,c Toxic 42
Nickelb Toxic 630
Phenolc Toxic 3.5 x 103
Organoleptic 3.0 x 102
TCDDa.C Carcinogenic 2.1 x 10-9
a Cocarcinogen.
b Promoter in vitro system.
c Promoter.
and chromium appear to have promoting/cocarcino-
genic activities in various experimental conditions.
Due to lack of any data indicating the potency of
promoting or cocarcinogenic activities, these biologi-
cal responses could not be used for human health
risk assessment in developing their criteria. Conse-
quently, the quantitative data base on other biologi-
cal responses to these chemicals are utilized in de-
veloping ambient water quality criteria.
Examples of Data on
Priority Pollutants
TCDD
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a
highly toxic and stable compound. It has been de-
monstrated to produce adverse effects after acute,
subchronic and chronic exposure in animals and
man. The carcinogenic potential of TCDD has been
established by feeding studies in rodents (18-21).
The animal bioassay data in combination with the
case-control studies suggest that TCDD is a poten-
tial human carcinogen (22-31).
Recently, TCDD has been shown to promote he-
patocarcinogenesis (32) as well as to act as a cocarci-
nogen in the development of sarcoma (33-35). For
example, the DBA/2N mouse strain, which responds
only weakly to the sarcomatogenic action of 3-me-
thylcholanthrene, becomes highly susceptible after
treatment with TCDD (32). In two inbred strains of
mice, C57BL/6Cum and DBA/2Cum, the ad-
ministration of TCDD simultaneously with 3-methyl-
cholanthrene appears to enhance the sarcomato-
genic response (34). These observations suggest that
TCDD acts as a cocarcinogen possibly by acting as
an inducer of aryl hydrocarbon hydroxylase at the
site of inoculation. Similarly, female Charles River
rats exhibited marked increases in hepatic enzyme
altered foci at TCDD doses of 0.14 and 1.4 pg/kg SC
(one every 2 weeks for 7 months), given after partial
hepatectomy and initiation with diethylnitrosamine
(10 mg/kg). Hepatocellular carcinomas wereobserved
at the higher TCDD dose; but no significant effects
were seen without prior initiation (32). This observa-
tion suggests that TCDD is a potent promoter for
hepatocarcinogenesis. Similar promoting action in
the development of fibrosarcoma of the integumen-
tary system was also observed in female (but not
male) Swiss-Webster mice initiated with dimethyl-
benzanthracene (50 ,xg) and exposed dermally to 5
ng of TCDD, 3 days/week for 104 weeks (35).
Because TCDD is a carcinogen, the recommended
AWQC for TCDD were based on carcinogenic data.
The levels which result in incremental increase of
human lifetime cancer risk due to exposure of
TCDD through ingestion of contaminated water and
contaminated aquatic organisms of 10- 5, 10- 6, and
10- 7 were estimated to be 2.1 x 10- 9pg/L, 2.1 x
10- 10 ,Ag/L and 2.1 x 10- 11 ,ug/L, respectively.
Phenol
Phenol has been reported to have tumor-promo-
ting activity in several strains of mice when applied
repeatedly to the shaved skin after initiation with
known carcinogens. The tumor-promoting activity is
highest at dose levels of phenol which have some sc-
lerosing activity, but it also occurs in sensitive
strains at concentrations which do not produce obvi-
ous skin damage.
The tumor-promoting activity of phenolic com-
pounds has been tested in various strains of mice
(36). Mice exposed to a single dose of the initiator
DMBA by skin painting were given repeated der-
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mal applications of selected phenols. In one experi-
ment in this series mice specially inbred for sensiti-
vity to develop tumors received a single application
of 75 jg DMBA to the shaved skin. This was fol-
lowed 1 week later by twice-weekly dermal applica-
tions of 2.5 mg phenol (as a 10% solution in benzene)
for 42 consecutive weeks. The mice subjected to the
skin application of phenol exhibited severe skin
damage, decreased body weight and increased mor-
tality. After 13 weeks, 22 of 23 mice had developed
papillomas, and 73% had developed carcinomas.
The skin painting with phenol was continued until
the 72nd week, at which time one fibrosarcoma was
diagnosed. It is worth mentioning here that these
effects can also be due to benzene, a leukemogenic
agent, which has been classified as a promoter (37).
"S" strain albino mice demonstrated strong tumor-
promoting activity after initiation with 0.3 mg
DMBA followed by repeated skin applications of
20% phenol, and a moderate promoting effect with
5% phenol (38). Dermally applied phenol (3
mg/mouse, 3 times/week) has been found to have
only slight promoting activity in ICR/Ha Swiss mice
after initiation with BaP (approximate 0.05%
solution) (39).
For comparison purposes, two approaches were
used to derive criterion levels for phenol. Based on
available toxicity data, the derived level was 3.5
mg/L. By using available organoleptic data, how-
ever, for controlling undesirable taste and odor
qualities of ambient water, the estimated level was
0.3 mg/L.
3-Chlorophenol
3-Chlorophenol has promoting action when ap-
plied to the skin of mice in a series of experiments
testing the tumor promoting action of substituted
phenols (36). A 20% solution of 3-chlorophenol in
benzene increased the number of papillomas follow-
ing initiation by DMBA. If skin papillomas are consi-
dered in this format (i.e., in relation to carcinogenici-
ty) then 3-chlorophenol exhibited a promoting ac-
tion. However, due to the lack of any methodology
for developing criteria based on promotion action,
the criteria for 3-chlorophenol was derived based on
available organoleptic data; the estimated level was
0.1 ,g/L.
24-Dichlorophenol
Similarly, in the-same series of experiments, 2-4-
dichlorophenol was found to have promotion action
on papillomas of the skin following initiation by
DMBA (36). Based on available toxicity and organo-
leptic data, the AWQC for 2,4-dichlorophenol were
estimated to be 3.1 mg[L and 0.3Mg/L, respectively.
Fluoranthene
Fluoranthene is a very weak tumor promoter on
mouse skin in comparison to the action of classical
tumor promoting chemicals such as phorbol myri-
state acetate (PMA) (the active component of croton
oil) (39). However, a remarkable aspect of the biolog-
ical activity of fluoranthene is its potency as a cocar-
cinogen. Two carefully conducted studies have
shown that fluoranthene acts as a cocarcinogen for
mouse skin cancer when applied with small quanti-
ties of benzo(a)pyrene (39,40).
Based on the use of chronic mouse toxicity data,
the ambient water quality criterion for fluoranthene
was estimated to be 42,g[L.
DDT
The liver tumorigenesis of DDT has been
demonstrated in mice (41-45) and in rats (46,47).
There is no epidemiological evidence relating to the
carcinogenicity of DDT. However, some investiga-
tors have detected DDT residues in cancer patients
(48, 49) and in some cases in cancerous tissue (50).
These observations, however, do not necessarily in-
dicate that DDT is carcinogenic in humans.
Cocarcinogenic activities of DDT have been de-
monstrated by coadministration of DDT with 2-ace-
tylaminofluorene (2-AAF) which enhanced the inci-
dence of liver tumors in rats (51).
Considering all the available data, the ambient
water quality criterion for DDT was derived from
carcinogenic response in mice and the criterion as-
sociated with a human lifetime cancer risk of 10-5
was determined to be 0.24 ng/L.
Dieldrin
Chronic ingestion of dieldrin, an environmental
and metabolic by-product of aldrin, a carcinogen,
produced liver tumors in several strains of mice
(45,52). These studies strongly suggest that dieldrin
may pose a carcinogenic risk to man. Cocarcinogenic
activities of dieldrin with DDT have also been de-
monstrated in mice (45). In light of the carcinogenic
data in animals, the ambient water quality criterion
for dieldrin was determined to be 0.71 ng/L in order
to maintain the additional lifetime human cancer
risk below 10-5.
Beryllium
The high frequency of osteosarcomas in rabbits
induced by intravenous injection of beryllium (53)
and of reticulum cell sarcomas in rats by oral inges-
tion of beryllium (54), the positive results from mu-
tagenic assays (55), and the suggestive human epide-
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miologic data (56,57) indicate that beryllium-laden
water poses a carcinogenic risk to man.
Data from a dietary study (58) was used to esti-
mate the criterion associated with a lifetime human
cancer risk of 10-5. The resulting ambient water
criterion was 68 ng/L. Regarding cocarcinogenicity,
it has been demonstrated that beryllium oxide can
potentiate the carcinogenicity of 3-methylcholan-
threne (59).
Other Metal Salts
Recently, it has been demonstrated in an in vitro
system with hamster embryo cells that certain
metal salts have a promotion-like effect similar to
that obtained with the tumor promoter TPA (12-0-
tetradecanoyl phorbol-13-acetate) (60). These results
indicated that nickel sulfate, cadmium acetate and
sodium chromate act as promoters in the transfor-
mation of cells initiated by BaP. In ambient water
quality criteria derivation, these metals have been
treated in the following way.
NickeL Although epidemiological data from oc-
cupational exposure to nickel compounds indicate
carcinogenic potential through inhalation, there is
no evidence for carcinogenicity of nickel compounds
after exposure from contaminated water. Ac-
cordingly, for the protection of human health, the
criterion for nickel was derived from the toxic prop-
erties of its salts ingested through contaminated
water and aquatic organisms. The criterion was de-
termined to be 630Mg/L.
Cadnium. The human evidence for the carcino-
genicity of cadmium is weak because it is based on
very small populations of workers and is accom-
panied by no clear-cut positive animals studies by
the oral route. Accordingly, the criterion for cad-
mium was based on established toxic effects (i.e.,
emphysema and renal tubular proteinuria). The rec-
ommended ambient water quality criterion for cad-
mium was 10 ig[L to protect against these toxic ef-
fects.
Chromium. Evidence suggests that inhaled hexa-
valent chromium is a human carcinogen. However,
the oral carcinogenicity of either hexavalent or tri-
valent chromium has not been demonstrated. Ac-
cordingly, the ambient water quality criterion for
chromium was based on its toxic properties and was
determined to be 50Mg/L.
Future Regulatory Considerations
Because some of these pollutants with promo-
tion/cocarcinogenic activities are present in environ-
mental mixtures together with other carcinogens,
they may present an additional risk to the exposed
population. Yet, because of the uncertainties as to
the degree of the promotionalcocarcinogenic activi-
ty of these chemicals, the degree of added risk can-
not be easily determined on the basis of present sci-
entific knowledge. Due to the close association be-
tween some of the promoters/cocarcinogens and
chemicals which are known carcinogens (initiators),
it would seem prudent to temporarily limit the level
of such pollutants in drinking water to the same
concentration as "complete" carcinogens using the
"linearized" multistage model. This approach can be
revised if a sufficient data base for a different ap-
proach becomes available.
Given the complexities of promotion/cocarcino-
genicity, it is not surprising that a definitive ap-
proach has not been recommended as yet for incor-
porating these concepts into a risk assessment
methodology. An efficient promoter might test also
as a weak or moderate "complete carcinogen" in a
normal bioassay for carcinogenicity, thus presenting
a dilemma in the risk assessment procedure. Consid-
eration may have to be given to apply different ex-
trapolation models to the two different types of re-
sponse. To further clarify this issue, it has been rec-
ommended that an attempt be made to evaluate
the potencies of promoters provided that such data
are available (61). This is certainly a worthy ap-
proach and appears to be the path that some re-
searchers are following. To increase, however, the
size and quality of the data base from which
correlations can be made and principles identified, it
also seems desirable to develop more efficient
screening tests for promoters.
Nonetheless, even if tumor promoters and cocar-
cinogens could be readily identified through
screening tests or whole animal bioassays, problems
would still remain in attempting to quantitatively
apply such data to human risk assessment. In
principle, some of these problems are the same as
those already faced in developing a risk assessment
approach for "complete carcinogens": the selection
of appropriate or most defensible models for high-
to-low dose and experimental animal-to-human ex-
trapolation as well as a method for choosing the
types of experimental data to use in the extrapola-
tion (e.g., periods of exposure and observation) of
lifetime risks. However, data on tumor promoters
and cocarcinogens present an additional set of con-
cerns similar to those which must be faced when
dealing with mixtures of toxic agents. Specifically,
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several major conceptual questions must be ad-
dressed before a satisfactory regulatory approach
can be developed:
* How specific and consistent are initiator-
promoter interactions? Does the promoting
efficiency of a compound vary with initiating
agents and, if so, does this variation follow a
consistent or predictable pattern?
* How does exposure to multiple promoting
agents affect the promoting efficiency of the in-
dividual promoters? If additivity is a reason-
able assumption, which type of additivity might
be expected based on what we know about the
mechanism of promotion?
* How does promoting efficiency vary with the
duration of exposure to the initiator and the
promoter?
* Is there any validity in using promotion data
from one route of administration to predict pro-
moting activity from another route of expo-
sure?
All of the above questions may apply equally to
cocarcinogens and the answers may or may not be
the same as those for promoters. Perhaps a more
fundamental question would be: What is the most
appropriate method for measuring promoting effici-
ency as a meaningful toxicologic parameter analo-
gous to potency?
The National Academy of Sciences, in its recent
review (62) on approaches to multiple chemical expo-
sures, did not address the problems associated with
promotion or cocarcinogenicity although it did out-
line approaches for dealing with mixtures of "com-
plete" carcinogens. Dose-response equations based
on Michaelis-Menton kinetics for cancer risk assess-
ment have been proposed (63), and it may be pos-
sible to use this general approach to describe the ef-
fects of promoters or cocarcinogens. Similarly, bio-
metricians may be able to construct modifications of
other dose-response models to describe the effects
of promoters or cocarcinogens on apparent carcino-
genic potency. However, the meaningfulness and
validity of any mathematic model will depend not
only on how well it fits dose-response data but also
on how well the mathematic constructs used to for-
mulate the model reflect an understanding of the
biologic basis of promotion and cocarcinogenicity.
Whether our current understanding of these phe-
nomena is sufficient to recommend a specific risk as-
sessment approach is perhaps the most basic ques-
tion of all. The EPA's Office of Health and Environ-
mental Assessment is currently examining this
issue internally using a review committee composed
of in-house, academnic and industrial scientists.
Various alternative approaches are being tested for
dealing with nongenotoxic carcinogens with and
without promotional or cocarcinogenic activity.
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